Healthcare - Biotechnology - NASDAQ - US
$ 9.53
-5.92 %
$ 202 M
Market Cap
-1.75
P/E
Price Target
Average
589.05%
Revenue Forecast
Estimate
48.01%
EBIT
Estimate
--15.04%
Net Income
Estimate
10.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Enanta Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ENTA of $65.7 , with forecasts ranging from a low of $54 to a high of $87 .
ENTA Lowest Price Target
Wall Street Target
54 USD
466.63%
ENTA Average Price Target
Wall Street Target
65.7 USD
589.05%
ENTA Highest Price Target
Wall Street Target
87 USD
812.91%
REVENUE FORECAST
Revenue Forecast Chart ENTA
EBIT FORECAST
EBIT Forecast Chart ENTA
NET INCOME FORECAST
Net Income Chart ENTA